Among all the other Remplir and/or Striate+ approvals pending shortly, there is also potentially less than 60 days before we unlock the US$1.2 billion+ rotator cuff tendon repair market with our third revenue generating product, SmrtGraft, to be approved in Australia (having regard to the TGA’s legislated review period deadline).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.015(1.24%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.20 | $621.0K | 510.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3346 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 5513 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| OCC (ASX) Chart |